Beilstein J. Org. Chem. 2012, 8, 2223–2229.
Acknowledgements
Grant financed by the Scholarship Council of the Scholarship
Foundation of the Republic of Austria is gratefully acknowl-
edged by Gytė Vilkauskaitė.
References
1. Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D. Pharmaceutical
Substances, 3rd ed.; Georg Thieme Verlag: Stuttgart/New York, 1999;
pp 1725–1727.
2. Boolell, M.; Gepi-Attee, S.; Gingell, J. C.; Allen, M. J. Br. J. Urol. 1996,
3. Pacher, P.; Nivorozhkin, A.; Szabó, C. Pharmacol. Rev. 2006, 58,
4. Elie, R.; Ruther, E.; Farr, I.; Emilien, G.; Salinas, E. J. Clin. Psychiatry
Figure 1: 1H NMR (in italics), 13C NMR and 15N NMR (in bold) chem-
ical shifts of 5d in CDCl3 solution (with numbering of ring atoms).
5. DeWald, H. A.; Lobbestael, S.; Butler, D. E. J. Med. Chem. 1977, 20,
6. Singh, S.; Sharma, P. K.; Dudhe, R.; Kumar, N. Pharma Sci. Monit.
2011, 2, 131–144.
13C and 15N NMR chemical shifts are displayed for model com-
7. Radi, M.; Dreassi, E.; Brullo, C.; Crespan, E.; Tintori, C.; Bernardo, V.;
Valoti, M.; Zamperini, C.; Daigl, H.; Musumeci, F.; Carraro, F.;
Naldini, A.; Filippi, I.; Maga, G.; Schenone, S.; Botta, M. J. Med. Chem.
pound 5d, for which also the numbering of ring atoms is given.
The obtained NMR spectroscopic data are inasmuch valuable as
the availability of reliable, unambiguously assigned chemical
shift data is important as reference material for NMR predic-
tion programs, such as CSEARCH/NMRPREDICT [34,35] or
ACD/C+H predictor [36]. Such programs have become more
and more popular in the past few years, particularly for the
prediction of 13C NMR chemical shifts. However, the quality of
such predictions is highly dependent on the disposability of
authentic reference data of related structures, a criterion which
is frequently not fulfilled for rare or new condensed hetero-
cyclic systems, such as those described here.
8. Honigberg, L. A.; Smith, A. M.; Sirisawad, M.; Verner, E.; Loury, D.;
Chang, B.; Li, S.; Pan, Z.; Thamm, D. H.; Miller, R. A.; Buggy, J. J.
Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 1375–1380.
9. Evans, L. E.; Cheeseman, M. D.; Jones, K. Org. Lett. 2012, 14,
10.Barrett, D.; Sasaki, H.; Kinoshita, T.; Fujikawa, A.; Sakane, K.
11.Mekheimer, R. A.; Ahmed, E. A.; Sadek, K. U. Tetrahedron 2012, 68,
12.Chen, Z.; Wu, J. Org. Lett. 2010, 12, 4856–4859.
13.Tonani, R.; Bindi, S.; Fancelli, D.; Pittala, V.; D’Anello, M.
Heterobicyclic Pyrazole Derivatives as Kinase Inhibitors. U.S. Patent
20060160874, July 20, 2006.
Conclusion
In conclusion, we present a simple and nonlaborious method to
access dipyrazolo[1,5-a:4',3'-c]pyridines from easily obtainable
5-alkynyl-1-phenyl-1H-pyrazole-4-carbaldehydes through a
silver triflate catalyzed one-pot tandem reaction with p-toluene-
sulfonyl hydrazide and an appropriate aldehyde or ketone.
Moreover, the novel heterocyclic system was investigated in
great detail by extensive NMR spectroscopic investigations
including also 15N. Further studies to exploit the synthetic
potential as well as the biological activities of the latter com-
pounds are in progress and will be published elsewhere.
14.Marson, C. M. Chem. Soc. Rev. 2011, 40, 5514–5533.
15.Eller, G. A.; Wimmer, V.; Haring, A. W.; Holzer, W. Synthesis 2006,
16.Eller, G. A.; Haring, A. W.; Datterl, B.; Zwettler, M.; Holzer, W.
17.Eller, G. A.; Holzer, W. Molecules 2007, 12, 60–73.
18.Eller, G. A.; Datterl, B.; Holzer, W. J. Heterocycl. Chem. 2007, 44,
19.Eller, G. A.; Zhang, Q.; Habicht, D.; Datterl, B.; Holzer, W.
Acta Chim. Slov. 2009, 56, 521–526.
20.Eller, G. A.; Habicht, D.; Holzer, D. Chem. Heterocycl. Compd. 2008,
Supporting Information
21.Arbačiauskienė, E.; Vilkauskaitė, G.; Šačkus, A.; Holzer, W.
22.Vilkauskaitė, G.; Šačkus, A.; Holzer, W. Eur. J. Org. Chem. 2011,
Supporting Information File 1
Experimental details and characterization data.
23.Isambert, N.; Lavilla, R. Chem.–Eur. J. 2008, 14, 8444–8454.
2228